Merck & Co., Inc.
Market Cap
$285.81B
P/E Ratio
15.88
EPS
$7.28
Dividend Yield
2.83%
52-Week Range
$73.31 — $125.14
Volume
3.91M
Avg Volume
12.59M
Beta
0.26
P/E (TTM)
15.88
Forward P/E
22.46
PEG Ratio
-4.13
P/S (TTM)
4.40
P/B (TTM)
5.48
P/FCF
0.00
EV/EBITDA
35.69x
EV/Sales
—
ROE (TTM)
0.36%
ROA (TTM)
0.13%
ROIC
0.00%
Gross Margin
0.82%
Operating Margin
0.41%
Net Margin
0.18%
Debt/Equity
0.96
Current Ratio
1.54
EPS Growth (YoY)
-0.19%
Revenue Growth (YoY)
+0.07%
EPS Growth (3Y)
+15.46%
EPS Growth (5Y)
+9.47%
Sales Growth (3Y)
+0.03%
Sales Growth (5Y)
+0.10%
EPS Est (This Year)
$5.15
EPS Est (Next Year)
$9.75
Dividend Yield
—
Annual Dividend
$0.85
Payout Ratio
0.71%
Frequency
—
Ex-Dividend Date
2025-12-15
Cash/Share
$5.85
Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $122.42(5.9% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
2.50B
Float
2.48B
Free Float %
99.21%
RSI (14)
64.41
SMA 20
$112.09
SMA 50
$106.95
SMA 200
$90.85
ATR (14)
3.19
Volatility (Week)
0.02%
Volatility (Month)
0.02%
Pattern
—
1 Day
-0.42%
1 Week
+1.13%
1 Month
+5.99%
3 Months
+35.78%
6 Months
+46.38%
1 Year
—
YTD
+10.05%
All-Time High
$122.66
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
US
Exchange
NYSE
IPO Date
1978-01-13
Employees
73000
CEO
Robert Davis
Index Membership
Dow Jones, S&P 500
Website
https://www.merck.com
Merck & Co., Inc. (MRK) is a healthcare company in the drug manufacturers - general industry listed on the NYSE. With a market capitalization of $285.81B, a P/E ratio of 15.88, and a dividend yield of 2.83%, MRK is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare MRK against other stocks using dozens of fundamental and technical filters.
Merck & Co., Inc. (MRK) has a trailing twelve-month (TTM) P/E ratio of 15.88. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Merck & Co., Inc. (MRK) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Merck & Co., Inc. (MRK) has a market capitalization of $285.81 billion, classifying it as a mega-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Buy" rating on Merck & Co., Inc. (MRK) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $122.42 implies 5.9% upside from the current price.
Merck & Co., Inc. (MRK) has returned +10.05% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.